Envista Holdings

NVST Mid Cap

Healthcare · Medical Instruments & Supplies

Updated: Apr 5, 2026, 17:43 UTC

$25.81

-0.35% today

52W: $14.22 – $30.42

52W Low: $14.22 Position: 71.5% 52W High: $30.42

🔗 Compare Brokers

Key Metrics

P/E Ratio

92.18x

Price-to-Earnings

Forward P/E

16.55x

Forward Price/Earnings

P/S Ratio

1.56x

Price-to-Sales

EV/EBITDA

12.77x

Enterprise Value/EBITDA

Div. Yield

—

Annual dividend yield

Market Cap

$4.2B

Market Capitalization

Revenue Growth

15%

YoY Revenue Growth

Profit Margin

1.73%

Net profit margin

ROE

1.56%

Return on Equity

Beta

0.98

Market sensitivity

Short Interest

4.98%

% of float sold short

Avg. Volume

2,939,911

Average daily volume

Valuation Analysis

Signal

Overvalued

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

12 analysts

Avg. Price Target

$28.67

+11.07% upside

Target Range

$19.00 – $35.00

About the Company

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the N

Sector: Healthcare Industry: Medical Instruments & Supplies Country: United States Employees: 12,000 Exchange: NYQ